combination therapy

Pharma

Kelun's sac-TMT win offers blueprint for Merck's global gap

The trial “delivers the first, direct proof-of-concept for an ADC replacing platinum-based chemo in a 1L NSCLC standard-of-care regimen,” Leerink said.

Angus Liu Jul 15, 2026 10:20am

FDA expands Padcev-Keytruda combo to more MIBC patients

Jul 10, 2026 1:10pm

yellow light street light traffic pause slow delay

Verastem mulls options on approved asset in pancreatic cancer

Jun 17, 2026 3:00pm

Lilly oncology chief ‘blown away’ by new Jaypirca CLL data

Jun 15, 2026 8:25am

ASCO: Incyte positions Monjuvi combo for first-line DLBCL

May 30, 2026 8:00am

Merck's Welireg surprisingly fails in first-line kidney cancer

Apr 21, 2026 10:00am